Your browser doesn't support javascript.
loading
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging.
Ottoy, Julie; Niemantsverdriet, Ellis; Verhaeghe, Jeroen; De Roeck, Ellen; Struyfs, Hanne; Somers, Charisse; Wyffels, Leonie; Ceyssens, Sarah; Van Mossevelde, Sara; Van den Bossche, Tobi; Van Broeckhoven, Christine; Ribbens, Annemie; Bjerke, Maria; Stroobants, Sigrid; Engelborghs, Sebastiaan; Staelens, Steven.
Afiliación
  • Ottoy J; Molecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
  • Niemantsverdriet E; Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Verhaeghe J; Molecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium.
  • De Roeck E; Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Struyfs H; Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Somers C; Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Wyffels L; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.
  • Ceyssens S; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.
  • Van Mossevelde S; Neurodegenerative Brain Diseases Group, Center for Molecular Neurology, VIB, Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Van den Bossche T; Neurodegenerative Brain Diseases Group, Center for Molecular Neurology, VIB, Antwerp, Belgium.
  • Van Broeckhoven C; Neurodegenerative Brain Diseases Group, Center for Molecular Neurology, VIB, Antwerp, Belgium; Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Ribbens A; Icometrix, R&D, Leuven, Belgium.
  • Bjerke M; Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Stroobants S; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.
  • Engelborghs S; Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
  • Staelens S; Molecular Imaging Center Antwerp, University of Antwerp, Antwerp, Belgium. Electronic address: steven.staelens@uantwerpen.be.
Neuroimage Clin ; 22: 101771, 2019.
Article en En | MEDLINE | ID: mdl-30927601

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores / Péptidos beta-Amiloides / Progresión de la Enfermedad / Enfermedad de Alzheimer / Disfunción Cognitiva / Hipocampo Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuroimage Clin Año: 2019 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores / Péptidos beta-Amiloides / Progresión de la Enfermedad / Enfermedad de Alzheimer / Disfunción Cognitiva / Hipocampo Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuroimage Clin Año: 2019 Tipo del documento: Article País de afiliación: Bélgica